Ardelyx, Inc.

NASDAQ:ARDX

Biotechnology

Healthcare
$3.06 -1.03%

-$0.06 today

Market cap
$769.20M
Beta
0.58
P/E (TTM)
-24.5
EPS (TTM)
-$0.24
52W Low $3.49High $8.40

Volume 3.39M

Average 3.58M

Income Statement

Follow revenue through to earnings.

Revenue

$407.32M

FY 2025 · Annual

+22.1% YoY

Operating Income

-$40.98M

FY 2025 · Annual

Net Income

-$61.60M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue10.1M52.16M124.46M333.62M407.32M
Cost of Revenue1M4.12M17.8M50.56M42.6M
Gross Profit9.1M48.04M106.66M283.06M364.72M
Gross Margin90.1%92.1%85.7%84.8%89.5%
Research & Development91.14M35.2M35.54M52.32M68.47M
Selling, General & Admin72.3M76.6M134.4M258.69M337.23M
Operating Expenses163.44M111.8M169.94M311.01M405.7M
Depreciation & Amortization2.81M1.14M1.29M2.06M3.06M
EBITDA(150.85M)(60.98M)(55.35M)(16.71M)(29.17M)
EBITDA Margin-1494.0%-116.9%-44.5%-5.0%-7.2%
Operating Income(154.35M)(63.76M)(63.28M)(27.95M)(40.98M)
Operating Margin-1528.6%-122.2%-50.8%-8.4%-10.1%
Interest Income00000
Interest Expense4.5M5.07M8.87M20.09M28.4M
Other Income / Expenses(3.82M)(3.44M)(2.24M)(10.92M)(19.65M)
Income Before Tax(158.16M)(67.2M)(65.52M)(38.87M)(60.63M)
Pre-Tax Margin-1566.4%-128.8%-52.6%-11.7%-14.9%
Income Tax Expense4K8K547K266K969K
Net Income(158.17M)(67.21M)(66.07M)(39.14M)(61.6M)
Net Margin-1566.5%-128.9%-53.1%-11.7%-15.1%
EPS (Basic)(1.52)(0.42)(0.30)(0.17)(0.26)
EPS (Diluted)(1.52)(0.42)(0.30)(0.17)(0.26)
Weighted Avg Shares104.21M158.69M219.33M235.23M241.03M
Weighted Avg Shares (Diluted)104.21M158.69M219.33M235.23M241.03M

ARDX Earnings Waterfall · TTM

NASDAQ:ARDX · Revenue to Net Income

Key Ratios

EPS$-0.24
Gross Margin91.9%
Net Margin-15.1%
P/E Ratio-309.6
P/S Ratio12.2

Analysis

$427.7M of revenue converted into -$58.1M of net income for the selected period. Gross margin is 91.9% and net margin is -15.1%, showing how much revenue survives after costs and taxes. EPS is $-0.24, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 3, 2026
8-KCurrent reportNov 3, 2026
4Statement of changes in beneficial ownershipAug 25, 2026
4Statement of changes in beneficial ownershipAug 25, 2026
4Statement of changes in beneficial ownershipAug 25, 2026

How much revenue does ARDX generate?

Ardelyx, Inc. (ARDX) reported $407.32M of revenue in fiscal 2025.

Is ARDX profitable?

Ardelyx, Inc. (ARDX) reported -$61.60M of net income, with a net margin of -15.1%.